SATEESH APTE, MD
Medical Practice at Commerce Cir, Pleasanton, CA

License number
California A37018
Category
Medical Practice
Type
Neurological Surgery
Address
Address
7066 Commerce Cir STE D, Pleasanton, CA 94588
Phone
(925) 828-1000

Personal information

See more information about SATEESH APTE at radaris.com
Name
Address
Phone
Sateesh Apte
650 Blue Spruce Dr, Danville, CA 94506
Sateesh N Apte
7066 Commerce Cir, Pleasanton, CA 94588
(925) 828-1000
Sateesh N Apte
44 White Pine Ln, Danville, CA 94506
Sateesh S Apte
38 Rosewood Ct, Danville, CA 94506
Sateesh S Apte
5139 Blackhawk Dr, Danville, CA 94506

Organization information

See more information about SATEESH APTE at bizstanding.com

Sateesh Apte MD

6670 Owens Dr, Pleasanton, CA 94588

Industry:
Neurosurgeon
Phone:
(925) 828-1000 (Phone)
Sateesh Narayan Apte

Professional information

Sateesh Apte Photo 1

Dr. Sateesh Apte, Pleasanton CA - MD (Doctor of Medicine)

Specialties:
Neurology, Psychiatry
Address:
6670 Owens Dr, Pleasanton 94588
7066 Commerce Cir SUITE D, Pleasanton 94588
(925) 828-1000 (Phone)
Languages:
English, French
Education:
Medical School
University of Pune / Armed Forces Medical College
Boston University Med Ctr/Univ Hp
Stanford University Hospital


Sateesh N Apte Photo 2

Sateesh N Apte, Pleasanton CA

Specialties:
Neurosurgeon
Address:
7066 Commerce Cir, Pleasanton, CA 94588
6670 Owens Dr, Pleasanton, CA 94588


Sateesh Apte Photo 3

Method For The Reduction Of Viral Loads In Patients Comprising The Administration Of -Deficient Human Immunodeficiency Virus (Hiv)

US Patent:
8124102, Feb 28, 2012
Filed:
Jan 21, 2009
Appl. No.:
12/321456
Inventors:
Sateesh Apte - Pleasanton CA, US
International Classification:
A61K 39/21
US Classification:
4242081
Abstract:
A therapeutic suspension for the treatment of human immunodeficiency virus type I (HIV-1) infection in humans using isolated and purified HIV-1 nef-deficient viral particles having a nef-deletion between the endonuclease cleavage sites Nco I and Xho I.


Sateesh Apte Photo 4

Pharmaceutical Compositions Comprising Attenuated Hiv-1 Nef-Deficient Viral Particles

US Patent:
7491400, Feb 17, 2009
Filed:
Mar 29, 2004
Appl. No.:
10/811725
Inventors:
Sateesh Apte - Pleasanton CA, US
Assignee:
Swiss Pacific Group, Ltd - Las Vegas NV
International Classification:
A61K 39/21
US Classification:
4242081, 435236
Abstract:
A therapeutic suspension for the treatment of human immunodeficiency virus type I (HIV-1) infection in humans using isolated and purified HIV-1 nef-deficient viral particles having a nef-deletion between the endonuclease cleavage sites Nco I and Xho I.